Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096954
Status:
COMPLETED
Last Update Posted:
2017-06-14
First Post:
2004-11-17
Brief Title:
A Prospective Randomized Double-Blind Study of the Efficacy of Omalizumab Xolair in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat EXACT
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Organization Data
Organization:
Genentech Inc
Class:
INDUSTRY
Study ID:
Q2982g
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genentech Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None